S1PR3 Human Pre-designed siRNA Set A contains three designed siRNAs for S1PR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1pr3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for S1pr3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1pr3 Rat Pre-designed siRNA Set A contains three designed siRNAs for S1pr3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1PR4 Human Pre-designed siRNA Set A contains three designed siRNAs for S1PR4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1pr4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for S1pr4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1pr4 Rat Pre-designed siRNA Set A contains three designed siRNAs for S1pr4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1PR5 Human Pre-designed siRNA Set A contains three designed siRNAs for S1PR5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1pr5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for S1pr5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

S1pr5 Rat Pre-designed siRNA Set A contains three designed siRNAs for S1pr5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

S2/IAPinh is a conjugate, which consist of an inhibitor for the apoptosis protein inhibitor (IAPinh) and a ligand for sigma 2 SW43. S2/IAPinh exhibits an anti-proliferative and apoptotic-inducing effect through degradation of the cellular inhibitor for apoptosis protein (clAP-1)[1].

SAA1 Human Pre-designed siRNA Set A contains three designed siRNAs for SAA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SAA2 Human Pre-designed siRNA Set A contains three designed siRNAs for SAA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SAA4 Human Pre-designed siRNA Set A contains three designed siRNAs for SAA4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SAAL1 Human Pre-designed siRNA Set A contains three designed siRNAs for SAAL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SAAP 148 is an antimicrobial and antibiofilm agent, and exhibits inhibitory efficacy against antibiotic-resistant pathogens, with LC50 of 0.8-12.8 μM[1].

SACM1L Human Pre-designed siRNA Set A contains three designed siRNAs for SACM1L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SACS Human Pre-designed siRNA Set A contains three designed siRNAs for SACS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Sacubitril-13C4 (AHU-377-13C4) is a 13C-labeled version of Sacubitril (HY-15407). Sacubitril is an orally active inhibitor of neprilysin NEP (IC50=5 nM). Sacubitril is used in research on heart failure, hypertension and COVID-19[1][2][3][4][5].

SAE1 Human Pre-designed siRNA Set A contains three designed siRNAs for SAE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SAFB Human Pre-designed siRNA Set A contains three designed siRNAs for SAFB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SAFB2 Human Pre-designed siRNA Set A contains three designed siRNAs for SAFB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Safotibant (LF22-0542) is a selective antagonist for kinin B1 receptor (BKB1R), with Ki of 0.35 and 6.5 nM, for human and mouse BKB1R, respectively. Safotibant exhibits analgesic and anti-inflammatory property in mice model[1][2].

SAG Human Pre-designed siRNA Set A contains three designed siRNAs for SAG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SAG-524 is a potent oral small molecule HBV viral replication inhibitor. SAG-524 decreased HBV-DNA and HbsAg levels in supernatant of HepG2.2.15 cells, IC50 0.92 and 1.4 nM, respectively[1].

SAGE1 Human Pre-designed siRNA Set A contains three designed siRNAs for SAGE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SAHA-BPyne is an activity-based protein profiling (ABPP) probe for detecting HDAC activity, which covalently labels the proximal proteins through a photoactivation. SAHA-BPyne inhibits HDAC activity in HeLa nuclear lysate with an IC50 of less than 5 μM[1].

Saintopin is an antitumor antibiotic. Saintopin is also an inhibitor of DNA topoisomerases I and II. Saintopin induces DNA cleavage[1][2].

Salbutamol (Standard) is the analytical standard of Salbutamol. This product is intended for research and analytical applications. Salbutamol (Albuterol) is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD)[1][2].

Salicylcurcumin is a synthetic curcumin analogue with antioxidant activity. Salicylcurcumin may affect lipid peroxidation in fish, favoring increased survival, disease resistance, and ultimately growth rate[1].

Salicylhydroxamic acid (2-Hydroxybenzohydroxamic acid; N,2-Dihydroxybenzamide) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

Salicyluric acid-d4 is deuterated labeled Salicyluric acid (HY-113295). Salicyluric acid is an endogenous metabolite.

Salixteroside D is a salicin derivative, that exhibits anti-inflammatory activity through inhibition of MAPK and NF-κB signaling pathways[1].

SALL1 Human Pre-designed siRNA Set A contains three designed siRNAs for SALL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SALL2 Human Pre-designed siRNA Set A contains three designed siRNAs for SALL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SALL3 Human Pre-designed siRNA Set A contains three designed siRNAs for SALL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SALL4 Human Pre-designed siRNA Set A contains three designed siRNAs for SALL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Salmine sulfate is an antimicrobial protein. Salmine sulfate is a polycationic coacervate embolic agent that can be used in tumor research[1][2].

SAMD1 Human Pre-designed siRNA Set A contains three designed siRNAs for SAMD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SAMD10 Human Pre-designed siRNA Set A contains three designed siRNAs for SAMD10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SAMD11 Human Pre-designed siRNA Set A contains three designed siRNAs for SAMD11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.